Near infrared optical applications in molecular imaging

Near infrared (NIR) optical imaging is a rapidly expanding newer technique that has combined research involving in vivo imaging technologies with research involving imaging probe design to help noninvasively evaluate important molecular events in vivo. This review details some of the advances in these areas that have allowed imaging of proteases, apoptosis, and cell surface receptors and details applications in diseases such as cancer, cardiovascular disease, and rheumatoid arthritis.

[1]  H. Rochefort,et al.  Cellular localisation byin situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer , 2005, Breast Cancer Research and Treatment.

[2]  Ralph Weissleder,et al.  Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. , 2004, Radiology.

[3]  O W Witte,et al.  Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[4]  Ralph Weissleder,et al.  A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. , 2003, Cancer research.

[5]  Chun Li,et al.  Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. , 2003, Cancer research.

[6]  Aleksander Sieroń,et al.  Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus. , 2003, Gastrointestinal endoscopy.

[7]  R. Weissleder,et al.  Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. , 2003, Bioconjugate chemistry.

[8]  Peter Niederer,et al.  Noninvasive measurement of regional cerebral blood flow and regional cerebral blood volume by near-infrared spectroscopy and indocyanine green dye dilution , 2003, NeuroImage.

[9]  Ralph Weissleder,et al.  Miniaturized multichannel near infrared endoscope for mouse imaging. , 2003, Molecular imaging.

[10]  P. Low,et al.  Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. , 2003, Journal of biomedical optics.

[11]  Ralph Weissleder,et al.  Novel Factor XIII Probes for Blood Coagulation Imaging , 2003, Chembiochem : a European journal of chemical biology.

[12]  T. Sutedja,et al.  Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients. , 2003, Lung cancer.

[13]  W. Kaiser,et al.  Noninvasive Diagnosis of Arthritis by Autofluorescence , 2003, Investigative radiology.

[14]  R. Weissleder,et al.  High efficiency synthesis of a bioconjugatable near-infrared fluorochrome. , 2003, Bioconjugate chemistry.

[15]  J. Ripoll,et al.  In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. , 2003, Medical physics.

[16]  Vasilis Ntziachristos,et al.  A submillimeter resolution fluorescence molecular imaging system for small animal imaging. , 2003, Medical physics.

[17]  Woo Kyung Moon,et al.  Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. , 2003, Bioconjugate chemistry.

[18]  Vasilis Ntziachristos,et al.  Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. , 2003, Neoplasia.

[19]  R. Weissleder,et al.  Near-infrared fluorescent imaging of tumor apoptosis. , 2003, Cancer research.

[20]  R. Weissleder,et al.  Synthesis and Properties of Sulfhydryl-Reactive Near-Infrared Cyanine Fluorochromes for Fluorescence Imaging , 2003, Molecular imaging.

[21]  B. Mayinger,et al.  Endoscopic light-induced autofluorescence spectroscopy for the diagnosis of colorectal cancer and adenoma. , 2003, Journal of photochemistry and photobiology. B, Biology.

[22]  H. Asanuma,et al.  Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy. , 2003, The Journal of urology.

[23]  R. Weissleder,et al.  Molecular imaging in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[24]  Georges Wagnières,et al.  In vivo autofluorescence imaging of early cancers in the human tracheobronchial tree with a spectrally optimized system. , 2003, Journal of biomedical optics.

[25]  R. Weissleder,et al.  In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[26]  W. Domschke,et al.  Fluorescence Endoscopy Using a Fluorescein-Labeled Monoclonal Antibody Against Carcinoembryonic Antigen in Patients with Colorectal Carcinoma and Adenoma , 2002, Endoscopy.

[27]  K. Shibuya,et al.  Spectroscopic analysis of the autofluorescence from human bronchus using an ultraviolet laser diode. , 2002, Journal of biomedical optics.

[28]  Roland Hustinx,et al.  Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  Woo Kyung Moon,et al.  A Receptor‐Targeted Near‐Infrared Fluorescence Probe for In Vivo Tumor Imaging , 2002, Chembiochem : a European journal of chemical biology.

[30]  J. Rassweiler,et al.  Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. , 2002, The Journal of urology.

[31]  Ralph Weissleder,et al.  Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. , 2002, Radiology.

[32]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[33]  Vasilis Ntziachristos,et al.  In Vivo Imaging of Proteolytic Activity in Atherosclerosis , 2002, Circulation.

[34]  Samuel Achilefu,et al.  Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. , 2002, Journal of medicinal chemistry.

[35]  Ralph Weissleder,et al.  Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. , 2002, Bioconjugate chemistry.

[36]  Ralph Weissleder,et al.  Ratio imaging of enzyme activity using dual wavelength optical reporters. , 2002, Molecular imaging.

[37]  R. Weissleder,et al.  Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. , 2002, Radiology.

[38]  Ralph Weissleder,et al.  A Novel Near‐Infrared Fluorescence Sensor for Detection of Thrombin Activation in Blood , 2002, Chembiochem : a European journal of chemical biology.

[39]  Thomas Dreyer,et al.  Autofluorescence Endoscopy in the Diagnosis of Early Laryngeal Cancer and Its Precursor Lesions , 2002, The Laryngoscope.

[40]  Ralph Weissleder,et al.  Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. , 2002, Gastroenterology.

[41]  Ralph Weissleder,et al.  Arthritis critically dependent on innate immune system players. , 2002, Immunity.

[42]  U. Prakash.  Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. , 2002 .

[43]  Marc Ruel,et al.  A new and simplified method for coronary and graft imaging during CABG. , 2002, The heart surgery forum.

[44]  Vasilis Ntziachristos,et al.  Would near-infrared fluorescence signals propagate through large human organs for clinical studies? , 2002, Optics letters.

[45]  R. Prosst,et al.  Fluorescence diagnosis of colorectal neoplasms: a review of clinical applications , 2002, International Journal of Colorectal Disease.

[46]  F. Blankenberg,et al.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection , 2001, Nature Medicine.

[47]  R Weissleder,et al.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. , 2001, Radiology.

[48]  E. G. Hahn,et al.  Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. , 2001, Gastrointestinal endoscopy.

[49]  R. Weissleder,et al.  Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. , 2001, Optics letters.

[50]  Ralph Weissleder,et al.  In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.

[51]  Michael R Hamblin,et al.  Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. , 2001, Cancer research.

[52]  S. Achilefu,et al.  Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.

[53]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[54]  K. Hahm,et al.  Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy , 2001, International Journal of Colorectal Disease.

[55]  W Semmler,et al.  Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes. , 2001, Bioconjugate chemistry.

[56]  K. Forde,et al.  Colonoscopy in Mice , 2001, Surgical Endoscopy And Other Interventional Techniques.

[57]  V. Ntziachristos,et al.  Hydrophilic Cyanine Dyes as Contrast Agents for Near-infrared Tumor Imaging: Synthesis, Photophysical Properties and Spectroscopic In vivo Characterization¶ , 2000, Photochemistry and photobiology.

[58]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[59]  Hans Christian Wulf,et al.  Autofluorescence spectrum of skin: component bands and body site variations , 2000, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[60]  V. Ntziachristos,et al.  Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  L. Svaasand,et al.  Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. , 2000, Neoplasia.

[62]  R Weissleder,et al.  Near-infrared optical imaging of protease activity for tumor detection. , 1999, Radiology.

[63]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[64]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[65]  R Weissleder,et al.  Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. , 1999, Bioconjugate chemistry.

[66]  B. Davidson,et al.  MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. , 1999, Gynecologic oncology.

[67]  I Itzkan,et al.  In vivo identification of colonic dysplasia using fluorescence endoscopic imaging. , 1999, Gastrointestinal endoscopy.

[68]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[69]  Y. Kaneko,et al.  Membrane‐type matrix metalloproteinase‐1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma , 1999, Cancer.

[70]  D. Benaron,et al.  Bedside Imaging of Intracranial Hemorrhage in the Neonate Using Light: Comparison with Ultrasound, Computed Tomography, and Magnetic Resonance Imaging , 1999, Pediatric Research.

[71]  N. Nishioka,et al.  Colonic polyp differentiation using time-resolved autofluorescence spectroscopy. , 1998, Gastrointestinal endoscopy.

[72]  W. Yu,et al.  Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.

[73]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[74]  R. Davis,et al.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[75]  H. Kanayama,et al.  Prognostic values of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 expression in bladder cancer , 1998 .

[76]  R E Jacobs,et al.  Fluorescently detectable magnetic resonance imaging agents. , 1998, Bioconjugate chemistry.

[77]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[78]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[79]  Bonnie F. Sloane,et al.  Tumor progression and angiogenesis: cathepsin B & Co. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[80]  Marcel Garcia,et al.  Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis , 1996, Stem cells.

[81]  H. Rochefort,et al.  Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[82]  T. Maudelonde,et al.  Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. , 1994, Human pathology.

[83]  H. Bergh,et al.  Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.

[84]  M. Davies,et al.  Atherosclerotic plaque caps are locally weakened when macrophages density is increased. , 1991, Atherosclerosis.

[85]  P. Pujol,et al.  Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. , 1990, Oncogene.